HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups. by Saarinen, S, Boberg, K, Spurkland, A, Mitchell, S, Broome, U, Rosina, F, Chapman, R, Pares, A, Olerup, O, Schrumpf, E

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. by Boberg, K, Spurkland, A, Rocca, G, Egeland, T, Saarinen, S, Mitchell, S, Broomé, U, Chapman, R, Olerup, O, Pares, A, Rosina, F, Schrumpf, E

T cell reactivity of defined peptides from a major Plasmodium falciparum vaccine candidate: the Pf155/RESA antigen. by Troye-Blomberg, M, Kabilan, L, Riley, E, Ortlund, J, Andersson, G, Perlmann, H, Olerup, O, Högh, B, Petersen, E, Snow, R

Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele. by Olerup, O, Broome, U, Einarsson, K, Zetterquist, H, Mehal, W, Wordsworth, B, Taylor, C, Bell, J, Fleming, K, Chapman, R, Min, S, Terasaki, P

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. by Spurkland, A, Saarinen, S, Boberg, K, Mitchell, S, Broome, U, Caballeria, L, Ciusani, E, Chapman, R, Ercilla, G, Fausa, O, Knutsen, I, Pares, A, Rosina, F, Olerup, O, Thorsby, E, Schrumpf, E